Monday, September 14, 2026

AI Development: Trump vs Obama – Who Should Control the Pace in 2026?

The U.S. political landscape is divided over the rapid development of artificial intelligence (AI).

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Tag: amphibious landing

No posts to display

Top News

- Our Sponsors Ad -

Follow us